5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.42▼ | 4.46▼ | 4.47▼ | 4.54▼ | 4.08▲ |
MA10 | 4.43▼ | 4.46▼ | 4.44▼ | 4.40▲ | 3.68▲ |
MA20 | 4.45▼ | 4.44▼ | 4.45▼ | 4.03▲ | 3.48▲ |
MA50 | 4.46▼ | 4.48▼ | 4.50▼ | 3.59▲ | 3.47▲ |
MA100 | 4.43▼ | 4.47▼ | 4.20▲ | 3.46▲ | 3.21▲ |
MA200 | 4.45▼ | 4.16▲ | 3.83▲ | 3.40▲ | 2.91▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | 0.005▲ | 0.001▲ | 0.032▲ | 0.139▲ |
RSI | 43.149▼ | 44.235▼ | 45.514▼ | 63.599▲ | 71.779▲ |
STOCH | 21.296 | 64.212 | 50.937 | 62.268 | 76.676 |
WILL %R | -87.500▼ | -67.647 | -73.171 | -45.333 | -33.010 |
CCI | -70.707 | -34.549 | -18.182 | 49.001 | 169.187▲ |
CDL | $ABUS Doji Candlestick Pattern Detected | Set Alert |
Monday, September 15, 2025 01:31 PM
Arbutus Biopharma (ABUS) is a clinical-stage biotech focused on LNP technology, with value now hinging on ongoing patent litigation against Moderna and Pfizer/BioNTech. Recent management changes and ...
|
Monday, September 15, 2025 08:19 AM
Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company focused on infectious disease, reported second quarter 2025 financial results and provided a corporate update.
|
Wednesday, August 20, 2025 05:58 AM
HOUSTON — Six more Houston-based companies have joined the New York Stock Exchange’s new Dallas-based electronic equities exchange in the past few days. All joined the NYSE Texas as founding members ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/09/25 | 4.415 | 4.535 | 4.365 | 4.42 | 765,088 |
16/09/25 | 4.52 | 4.57 | 4.38 | 4.40 | 1,011,920 |
15/09/25 | 4.50 | 4.565 | 4.37 | 4.53 | 968,331 |
12/09/25 | 4.89 | 4.89 | 4.45 | 4.46 | 1,689,712 |
11/09/25 | 4.65 | 5.10 | 4.59 | 4.90 | 5,051,456 |
10/09/25 | 4.44 | 4.69 | 4.39 | 4.62 | 2,608,556 |
09/09/25 | 4.08 | 4.36 | 4.015 | 4.33 | 2,858,014 |
08/09/25 | 4.22 | 4.24 | 4.06 | 4.09 | 989,837 |
05/09/25 | 4.00 | 4.37 | 4.00 | 4.20 | 2,833,764 |
04/09/25 | 3.95 | 4.03 | 3.88 | 4.01 | 1,046,769 |
|
|
||||
|
|
||||
|
|